PubMed COVID-19 Clinical Care

No abstract

The COVID-19 outbreak has emerged as one of the most profound medical events of the 21st century, leaving an indelible impact on a global scale. The widespread prevalence causing significant illness and death needs collaborative and inventive efforts

SARS-CoV-2 3-chymotrypsin-like protease (3CL^(pro)) is considered an attractive target for the development of anti-COVID-19 agents due to its vital function. The N-substituted isatin derivative L-26 is a potential SARS-CoV-2 3CL^(pro) inhibitor, but

CONCLUSIONS: This study adds to the existing literature on pandemic preparedness and highlights the need for greater outreach and education among racial and ethnic minorities.

It is challenging to estimate local emission conditions of a downwind area solely based on concentrations in the downwind area. This is because air pollutants that have a long residence time in the atmosphere can be transported over long distances

BACKGROUND: An improved estimation of the clinical sequelae of SARS-CoV-2 infection is crucial in African countries, where the subject has received little attention despite more than 12 million reported cases and evidence that many more people were

The COVID-19 pandemic has posed significant challenges for U.S. workers, especially those in essential occupations. As most public health experts view vaccination as the only certain path to defeating the virus, this study examines how union

Septic shock can be caused by a variety of mechanisms including direct effects of bacterial toxins such as endotoxin. Annually, approximately 5-7 million patients worldwide develop sepsis with very high endotoxin activity in the blood and more than

CONCLUSIONS: To improve IPC in disability care settings, the implementation of tailored and structural IPC education and training programmes (e.g., on-the-job training) is recommended to increase HCWs' capabilities and bridge the IPC compliance gap

CONCLUSIONS: We showed the effectiveness of a knowledge graph-based approach in potential target discovery and drug repurposing for coronaviruses. Our approach can be extended to other viruses or diseases for biomedical knowledge discovery and